Market open
Alcon/$ALC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alcon
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Ticker
$ALC
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Geneva, Switzerland
Employees
25,599
Website
Alcon Metrics
BasicAdvanced
$47B
45.71
$2.05
0.83
$0.16
0.19%
Price and volume
Market cap
$47B
Beta
0.83
52-week high
$99.64
52-week low
$77.54
Average daily volume
1.7M
Dividend rate
$0.16
Financial strength
Current ratio
2.77
Quick ratio
1.709
Long term debt to equity
23.046
Total debt to equity
23.848
Dividend payout ratio (TTM)
12.77%
Interest coverage (TTM)
7.13%
Management effectiveness
Return on assets (TTM)
2.85%
Return on equity (TTM)
4.83%
Valuation
Price to earnings (TTM)
45.707
Price to revenue (TTM)
4.674
Price to book
1.79
Price to tangible book (TTM)
9.59
Price to free cash flow (TTM)
32.925
Dividend yield (TTM)
0.17%
Forward dividend yield
0.19%
Growth
Revenue change (TTM)
4.82%
Earnings per share change (TTM)
4.59%
3-year revenue growth (CAGR)
6.13%
3-year earnings per share growth (CAGR)
39.20%
3-year dividend per share growth (CAGR)
12.09%
What the Analysts think about Alcon
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Alcon stock.
Alcon Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Alcon Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Alcon News
AllArticlesVideos
Alcon Publishes Agenda for 2025 Annual General Meeting
Business Wire·3 weeks ago
Alcon Publishes Agenda for 2025 Annual General Meeting
Business Wire·3 weeks ago
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Alcon stock?
Alcon (ALC) has a market cap of $47B as of April 24, 2025.
What is the P/E ratio for Alcon stock?
The price to earnings (P/E) ratio for Alcon (ALC) stock is 45.71 as of April 24, 2025.
Does Alcon stock pay dividends?
Yes, the Alcon (ALC) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $0.156 and the yield is 0.19%. Alcon has a payout ratio of 12.77% on a trailing twelve-month basis.
When is the next Alcon dividend payment date?
The next Alcon (ALC) dividend payment date is unconfirmed.
What is the beta indicator for Alcon?
Alcon (ALC) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.